Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 2598Healthcare 740Technology 413Industrials 325Financial Services 253Consumer Cyclical 199Basic Materials 165Communication Services 133Energy 129Consumer Defensive 94Real Estate 88Utilities 59
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SSIISS Innovations International Inc. | Healthcare | Nov 17 | Sep '26 | $6.0M | n/m | −$6.0M | n/m | −$0.03 | n/m | -95.7% | — | $269M |
| OSTXOS Therapies Incorporated | Healthcare | Nov 17 | Sep '26 | $0.0M | n/m | −$11.28B | n/m | −$0.23 | n/m | — | — | $35M |
| NNVCNanoViricides, Inc. | Healthcare | Nov 17 | Sep '26pending | — | — | — | — | — | — | — | — | $30M |
| PULMPulmatrix, Inc. | Healthcare | Nov 17 | Sep '26pending | — | — | — | — | — | — | — | — | $5M |
| ISPCiSpecimen Inc. | Healthcare | Nov 17 | Sep '26pending | $0.2M† | n/m | — | — | — | — | — | — | $1M |
| OMEROmeros Corporation | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$57.0M | n/m | −$0.79 | n/m | — | — | $988M |
| ORICOric Pharmaceuticals, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$48.0M | n/m | −$0.44 | n/m | — | — | $801M |
| PMIPicard Medical, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$0.95 | n/m | -968.2% | — | $747M |
| APMDApnimed, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | — | −$30.0M | — | −$1.05 | — | — | — | $722M |
| HELPHelus Pharma Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$101M | n/m | −$1.39 | n/m | — | — | $452M |
| LRMRLarimar Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$31.0M | n/m | $0.00 | n/m | — | — | $314M |
| MPLTMapLight Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$52.0M | n/m | −$0.97 | n/m | — | — | $278M |
| GLSIGreenwich LifeSciences, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$0.40 | n/m | — | — | $269M |
| ENTAEnanta Pharmaceuticals, Inc. | Healthcare | Nov 16 | Sep '26 | $13.0M | −13.3% | −$24.0M | n/m | −$0.53 | n/m | -171.3% | −49.7 pp | $269M |
| LXEOLexeo Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$38.0M | n/m | −$0.43 | n/m | — | — | $246M |
| NGENNervGen Pharma Corp. | Healthcare | Nov 16 | Sep '26pending | — | — | — | — | — | — | — | — | $217M |
| PRLDPrelude Therapeutics Incorporated | Healthcare | Nov 16 | Sep '26 | $6.0M | −14.3% | −$13.0M | n/m | −$0.12 | n/m | -252.6% | +61.5 pp | $191M |
| GALTGalectin Therapeutics Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.04 | n/m | — | — | $190M |
| IVVDInvivyd, Inc. | Healthcare | Nov 16 | Sep '26 | $15.0M | +15.4% | −$33.0M | n/m | −$0.10 | n/m | -224.5% | −140.5 pp | $148M |
| GLASGlass House Brands Inc. Subordinate Voting Shares | Healthcare | Nov 16 | Sep '26pending | $56.8M† | +49.5% | — | — | — | — | — | — | $143M |
| ALXOALX Oncology Holdings Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$22.0M | n/m | −$0.15 | n/m | — | — | $139M |
| IAMIambic Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26pending | $11.3M† | — | — | — | — | — | — | — | $133M |
| CNTNCanton Strategic Holdings, Inc. | Healthcare | Nov 16 | Sep '26 | $3.0M | n/m | −$35.0M | n/m | −$0.16 | n/m | 11.2% | — | $114M |
| UNCYUnicycive Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$7.0M | n/m | −$0.25 | n/m | — | — | $103M |
| NRXPNRX Pharmaceuticals, Inc. | Healthcare | Nov 16 | Sep '26 | $1.0M | n/m | −$2.0M | n/m | −$0.05 | n/m | -702.8% | — | $100M |
| GNLXGenelux Corporation | Healthcare | Nov 16 | Sep '26pending | — | — | — | — | — | — | — | — | $90M |
| ACRVAcrivon Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$18.0M | n/m | −$0.42 | n/m | — | — | $64M |
| NMRANeumora Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$34.0M | n/m | −$0.18 | n/m | — | — | $58M |
| IMDXInsight Molecular Diagnostics Inc. | Healthcare | Nov 16 | Sep '26 | $1.0M | n/m | −$4.0M | n/m | −$0.10 | n/m | -657.6% | — | $58M |
| POCIPrecision Optics Corporation, Inc. | Healthcare | Nov 16 | Sep '26 | $8.0M | +14.3% | $0.0M | n/m | −$0.04 | n/m | -6.4% | +17.5 pp | $46M |
| ATNMActinium Pharmaceuticals, Inc. (Delaware) | Healthcare | Nov 16 | Sep '26pending | — | — | — | — | — | — | — | — | $42M |
| CNTBConnect Biopharma Holdings Limited | Healthcare | Nov 16 | Sep '26 | $0.0M | — | −$16.0M | — | −$0.26 | — | — | — | $38M |
| TILInstil Bio, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.62 | n/m | — | — | $35M |
| RPIDRapid Micro Biosystems, Inc. | Healthcare | Nov 16 | Sep '26 | $10.0M | +25.0% | −$11.0M | n/m | −$0.23 | n/m | -111.7% | +33.4 pp | $34M |
| NMADNomad Power Solutions, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$14.0M | n/m | −$0.74 | n/m | — | — | $30M |
| RNTXRein Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$0.06 | n/m | — | — | $29M |
| XTNTXtant Medical Holdings, Inc. | Healthcare | Nov 16 | Sep '26 | $24.0M | −27.3% | −$4.0M | −500.0% | −$0.03 | −400.0% | -12.5% | −20.1 pp | $29M |
| AYTUAytu BioPharma, Inc. | Healthcare | Nov 16 | Sep '26 | $15.0M | +7.1% | −$4.0M | −300.0% | −$0.20 | n/m | -26.5% | −15.6 pp | $29M |
| ONMDOneMedNet Corp | Healthcare | Nov 16 | Sep '26 | $1.0M | n/m | −$3.0M | n/m | −$0.43 | n/m | -218.4% | — | $29M |
| CUECue Biopharma, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$50.0M | n/m | −$4.74 | n/m | — | — | $28M |
| TVGNTevogen Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$7.0M | n/m | −$1.76 | n/m | — | — | $25M |
| GRDXGridAI Technologies Corp. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$0.27 | n/m | — | — | $23M |
| COCPCocrystal Pharma, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$0.20 | n/m | — | — | $20M |
| RVPRetractable Technologies, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$2.0M | n/m | −$0.08 | n/m | — | — | $17M |
| MODDModular Medical, Inc. | Healthcare | Nov 16 | Sep '26pending | — | — | — | — | — | — | — | — | $15M |
| MRKRMarker Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | −100.0% | −$2.0M | n/m | −$0.10 | n/m | — | — | $15M |
| ESLAEstrella Immunopharma, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$7.0M | n/m | −$0.17 | n/m | — | — | $15M |
| LONALeonaBio, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | n/m | −$21.0M | n/m | −$0.89 | n/m | — | — | $12M |
| JSPRJasper Therapeutics, Inc. | Healthcare | Nov 16 | Sep '26 | $8.0M | n/m | $0.0M | n/m | −$13.97 | n/m | — | — | $12M |
| PTNPalatin Technologies, Inc. | Healthcare | Nov 16 | Sep '26 | $0.0M | −100.0% | −$5.0M | −200.0% | −$1.29 | −130.3% | — | — | $10M |
- Report dates come from the earnings calendar (dates loaded Oct 3 to Dec 8); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.